NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
52 hedge funds and large institutions have $8.72M invested in Navidea Biopharmaceuticals Inc. in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 4 closing their positions.
Holders
52
Holders Change
-4
Holders Change %
-7.14%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
16
Reduced
8
Closed
4
Calls
$15K
Puts
$66K
Net Calls
-$51K
Net Calls Change
+$16K
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
D.E. Shaw & Co
New York
| – | – | -244,395 | Closed |
|
|
ARTA
52
A.R.T. Advisors
New York
| – | – | -51,700 | Closed |
|
|
EWA
53
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
| – | – | -30,000 | Closed |
|
|
TSS
54
Two Sigma Securities
New York
| – | – | -26,823 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
56
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
57
Barclays
London,
United Kingdom
| $0 | 23 | – | – |
|
|
SQA
58
Simon Quick Advisors
Morristown,
New Jersey
| $0 | 200 | – | – |
|